Outsourcing-pharma2d
General Inception acquires Enable Medicine to harness AI in drug discovery
Is the key to curing the world’s most challenging diseases hidden in unlocking the power of fragmented biological data?
Outsourcing-pharma2d
Noema Pharma raises $147 million to develop drugs for neurological conditions
Noema Pharma extends its series B funding to $147M, advancing phase 2 trials for CNS disorders like Tourette syndrome, ...
Outsourcing-pharma4d
AbbVie’s Parkinson’s disease monotherapy achieves positive phase 3 results
“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...
Outsourcing-pharma4d
Eli Lilly invests $3bn in injectable drug manufacturing facility
Including the acquisition and expansion of the manufacturing facility, Eli Lilly will be investing $4bn in the site. After ...
Outsourcing-pharma11d
Novocure reports positive phase 3 results for tumor treating fields therapy
Novocure's PANOVA-3 trial shows TTFields therapy with chemotherapy improves survival in pancreatic cancer, marking a ...
Outsourcing-pharma9d
Top 5 radiopharmaceuticals startups with VC backing
Radiopharmaceuticals have also been the target of large partnership deals, including a recent $140 million partnership ...
Outsourcing-pharma9d
Mitsubishi teams up with Dewpoint in $480m ALS deal
As part of the deal, Dewpoint can expect an undisclosed upfront payment from Mitsubishi Tanabe Pharma Corporation (MTPC) in ...
Outsourcing-pharma11d
Körber absorbs Wilhelm Bähren to expand pharma packaging toolbox
Discover how a strategic acquisition in pharma packaging is set to drive growth as the market aims to double by 2028 ...
Outsourcing-pharma11d
PTC Therapeutics boosted by Novartis rights deal for Huntington’s program
The potential $2.9 billion deal stands the New Jersey company in good stead after recent disappointing results in its ALS ...